Medicinal cannabis is an unapproved medicine. By agreeing to Mediflora's Consent for Unapproved Medicines before this consultation, you provide consent to be prescribed an unapproved medicine (if deemed suitable) and acknowledge the associated risks, restrictions, and possible complications outlined below.
By signing this document, I acknowledge that I understand and agree to the following:
Mediflora using its formulary will attempt to potentially prescribe products that are in stock. However, this may not always be possible, especially with any repeats. Mediflora will support patients to edit scripts should they prescribe something that is out of stock, however if a product is not in our formulary we will potentially have to charge you to change your script (where appropriate) and cannot guarantee delivery times of some medications. Delivery wait times or other issues are out of our control.
When prescribing medicinal cannabis, Mediflora must stay within TGA-approved THC limits. This is essential for patient safety and regulatory compliance. We follow the NIIM guidelines here https://niim.com.au/wp-content/uploads/2020/07/NIIM%20HREC%20APS%20MC%20Dosing%20Guidelines.pdf
